RE:Cronos Group Finally Files Q3 Results, Announces Business ReAnd so, since we don't know the impairment figures for Q2, I believe the stock will sink much lower than the recent 4 1/2 year low of $.3.95 CDN (Nov. 2017).
It's interesting how the stock is run up and down prior to earnings---when any informed trader or investor knows that CRON would report a significant impairment charge for Q3.
Now, we know that CRON must revise its Q2 earnings, which will likely tank the stock lower....
Meanwhile, traders will the stock up and down, giving potential investors a false sense of security about price movement.
In my opinion, now is NOT the time to buy CRON, even at $4.44.., given the risks/